Ansa Biotechnologies

BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
Ansa Biotechnologies, Inc. today announced that it is expanding its early access program for its complex DNA synthesis services.
Ansa Biotechnologies, Inc. today announced its speaker lineup for presentations at the upcoming Global Synthetic Biology (SynBioBeta) Conference in San Jose, Calif., from May 6-9, 2024.
Ansa Biotechnologies, Inc. , a pioneer of next-generation DNA synthesis, today announced the appointment of Jason T. Gammack as its new chief executive officer.
Ansa Biotechnologies, Inc will present more information regarding these milestones at the SynBioBeta conference on Wednesday, May 24, 2023, at 11:46 a.m. PT.
Ansa Biotechnologies, Inc today announced the successful de novo synthesis of the world’s longest DNA oligonucleotide ever reported to be produced in a single synthesis.
Ansa Biotechnologies today announced the appointment of Matthew F. McManus, M.D, Ph.D., as Independent Director and Chairperson of the company’s Board of Directors.
  • NextGen Class of 2023